» Articles » PMID: 39363035

The Therapeutic Potential of Exosome Therapy in Sepsis Management: Addressing Complications and Improving Outcomes"

Overview
Date 2024 Oct 3
PMID 39363035
Authors
Affiliations
Soon will be listed here.
Abstract

Infection occurs when pathogens penetrate tissues, reproduce, and trigger a host response to both the infectious agents and their toxins. A diverse array of pathogens, including viruses and bacteria, can cause infections. The host's immune system employs several mechanisms to combat these infections, typically involving an innate inflammatory response. Inflammation is a complex biological reaction that can affect various parts of the body and is a key component of the response to harmful stimuli. Sepsis arises when the body's response to infection leads to widespread damage to tissues and organs, potentially resulting in severe outcomes or death. The initial phase of sepsis involves immune system suppression. Early identification and targeted management are crucial for improving sepsis outcomes. Common treatment approaches include antibiotics, intravenous fluids, blood cultures, and monitoring urine output. This study explores the potential of exosome therapy in enhancing the management and alleviation of sepsis symptoms.

References
1.
Huang W, Meng L, Chen Y, Dong Z, Peng Q . Bacterial outer membrane vesicles as potential biological nanomaterials for antibacterial therapy. Acta Biomater. 2021; 140:102-115. DOI: 10.1016/j.actbio.2021.12.005. View

2.
Schwartz K, Morris S . Travel and the Spread of Drug-Resistant Bacteria. Curr Infect Dis Rep. 2018; 20(9):29. DOI: 10.1007/s11908-018-0634-9. View

3.
Hansen E, Karslake J, Woods R, Read A, Wood K . Antibiotics can be used to contain drug-resistant bacteria by maintaining sufficiently large sensitive populations. PLoS Biol. 2020; 18(5):e3000713. PMC: 7266357. DOI: 10.1371/journal.pbio.3000713. View

4.
Gupta V, Datta P . Next-generation strategy for treating drug resistant bacteria: Antibiotic hybrids. Indian J Med Res. 2019; 149(2):97-106. PMC: 6563750. DOI: 10.4103/ijmr.IJMR_755_18. View

5.
Furuyama N, Sircili M . Outer Membrane Vesicles (OMVs) Produced by Gram-Negative Bacteria: Structure, Functions, Biogenesis, and Vaccine Application. Biomed Res Int. 2021; 2021:1490732. PMC: 8016564. DOI: 10.1155/2021/1490732. View